Effects of psilocybin and related compounds on cerebroprotection during ischemic stroke (Stage 1 Registered Report)
November 17, 2025 Ruslan Rust
Stroke remains a leading cause of death and long-term disability and stroke patients have only limited treatment options.Recent preclinical evidence suggests that psychedelics such as psilocybin may confer cerebroprotection by engaging serotonin (5-HT) receptor pathways, yet their cellular targets and translational potential remain poorly understood.Here, we propose to systematically evaluate...